Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial-Reference-Cited by-同舟云学术

Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial

Published:2016-05-12 Issue: Volume: Page:euw064
ISSN:1099-5129
Container-title:Europace
language:en
Short-container-title:Europace

Author:

Katritsis Demosthenes G.,Zografos Theodoros,Katritsis George D.,Giazitzoglou Eleftherios,Vachliotis Vasilios,Paxinos George,Camm Alan John,Josephson Mark E.

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/19/4/602/13692114/euw064.pdf

Reference20 articles.

1. Oral Verapamil for Paroxysmal Supraventricular Tachycardia

2. Long-term therapy of paroxysmal supraventricular tachycardia: A randomized, double-blind comparison of digoxin, propranolol and verapamil

3. Antiarrhythmic actions of diltiazem during experimental atrioventricular reentrant tachycardias. Importance of use-dependent calcium channel-blocking properties.

4. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia

5. Flecainide acetate for paroxysmal supraventricular tachyarrhythmias

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of atrial fibrillation in patients with atrioventricular nodal re-entrant tachycardia and its association with long-term outcome;Heart Rhythm O2;2024-08

2. Recurrent episodes of atrioventricular nodal reentrant tachycardia: Sites of ablation success, ablation endpoint, and primary culprits for recurrence;Journal of Arrhythmia;2024-05-14

3. Diagnosis and Management of Paroxysmal Supraventricular Tachycardia;JAMA;2024-02-20

4. The Fluoroless Future in Electrophysiology: A State-of-the-Art Review;Diagnostics;2024-01-14

5. Two decades of SVT ablation in Denmark: a trend towards higher age, more comorbidity, and less prior use of antiarrhythmic and rate-limiting pharmacotherapy—a nationwide registry-based Danish study;Journal of Interventional Cardiac Electrophysiology;2023-12-18